Biomedical Engineering Reference
In-Depth Information
years, residual immunological differences between donor tissue and the recipient
immune system still restrict current clinical applications of allogeneic and xeno-
geneic grafts. Thus, prospective scientific efforts will be focused on the development
of strategies for in vitro or improved/accelerated in situ autologization of these
tissues to overcome this last major barrier of bioartificial tissue implantation.
References
1. Vacanti JP, Langer R (1999) Tissue engineering: the design and fabrication of living
replacement
devices
for
surgical
reconstruction
and
transplantation.
Lancet
354(Suppl
1):32-34
2. Skalak R, Fox C (1988) Tissue engineering. In: Skalak R, Fox C (eds) Workshop on tissue
engineering 26-29.02.1988, Granlibakken, Lake Tahoe, CA, USA. Liss, New York
3. Murphy JB (1897) Resection of arteries and veins injured in continuity—end-to-end suture:
experimental results and clinical research. Med Res 31:73-88
4. Carrel A (1902) La technique operatoire des anastomoses vascularies at le transplantation des
visceres. Lyon Med 89
5. Goyanes J (1906) Nuevos trabajos de cirurgia vascular. Siglo Med 53:446-561
6. Hufnagel CA (1947) Preserved homologous arterial transplants. Bull Am Coll Surg 32:231
7. Gross RE, Bill AH (1948) Preliminary observations on the use of the human arterial grafts in
the treatment of certain cardiovascular defects. N Engl J Med 239:578-591
8. Gross RE, Bill AH, Preice EC (1949) Methods for preservation and transplantation of arterial
grafts: observations on arterial grafts in dogs; report on transplantation of preserved arterial
grafts in nine human cases. Surg Gynecol Obstet 88:68-71
9. Barratt-Boyes BG (1965) A method for preparing and inserting a homograft aortic valve. Br J
Surg 52:847-856
10. Ross D (1967) Homograft replacement of the aortic valve. Br J Surg 54:842-843
11. Szilagyi DE, McDonald RT, Smith RF (1957) Biologic fate of human arterial homografts.
Arch Surg 75:506-529
12. Crawford ES et al (1960) Evaluation of late failures after reconstructive operations for
occlusive lesions of the aorta and iliac, femoral, and popliteal arteries. Surgery 47:79-104
13. Outdot J (1951) La greffe vasculaire dans les thromboses du Carrefour aortique. Presse Med 59:234
14. Outdot J, Beaconsfield P (1953) Thromboses of the aortic bifurcation treated by resection and
homograft replacement. Arch Surg 66:365-374
15. Dubost C, Allary M, Oeconomos N (1952) Resection of an aneurysm of the abdominal aorta:
reestablishment of the continuity by a preserved human arterial graft, with result after five
months. Arch Surg 64:405-408
16. Rosenberg NG, Henderson J (1956) The use of segmental arterial implants prepared by
enzymatic modification of heterologous blood vessels. Surg Forum 6:242
17. Rosenberg N (1976) The bovine arterial graft and its several applications. Surg Gynecol
Obstet 142(1):104-108
18. Dardik I, Darkik H (1973) Vascular heterograft: human umbilical cord vein as an aortic
substitute in baboon. A preliminary report. J Med Primatol 2(5):296-301
19. Kunlin J (1949) Le traitement de lìschemie obliterante par la greffe veineuse longue. Arch
Mal Couer 42: 371-372
20. Wilhelmi MH et al (2003) Role of inflammation and ischemia after implantation of
xenogeneic pulmonary valve conduits: histological evaluation after 6 to 12 months in sheep.
Int J Artif Organs 26(5):411-420
21. Wilhelmi MH et al (2003) Role of inflammation in allogeneic and xenogeneic heart valve
degeneration: immunohistochemical evaluation of inflammatory endothelial cell activation.
J Heart Valve Dis 12(4): 520-526
Search WWH ::
Custom Search